Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
mBio. 2024 Oct 16;15(10):e0322023. doi: 10.1128/mbio.03220-23. Epub 2024 Sep 16.
Due to the incessant emergence of various SARS-CoV-2 variants with enhanced fitness in the human population, controlling the COVID-19 pandemic has been challenging. Understanding how the virus enhances its fitness during a pandemic could offer valuable insights for more effective control of viral epidemics. In this manuscript, we review the evolution of SARS-CoV-2 from early 2022 to the end of 2023-from Omicron BA.2 to XBB descendants. Focusing on viral evolution during this period, we provide concrete examples that SARS-CoV-2 has increased its fitness by enhancing several functions of the spike (S) protein, including its binding affinity to the ACE2 receptor and its ability to evade humoral immunity. Furthermore, we explore how specific mutations modify these functions of the S protein through structural alterations. This review provides evolutionary, molecular, and structural insights into how SARS-CoV-2 has increased its fitness and repeatedly caused epidemic surges during the pandemic.
由于各种在人类中具有更高适应性的 SARS-CoV-2 变体不断出现,控制 COVID-19 大流行一直具有挑战性。了解病毒在大流行期间如何提高其适应性,可以为更有效地控制病毒流行提供有价值的见解。在本文中,我们回顾了 SARS-CoV-2 从 2022 年初到 2023 年底(从奥密克戎 BA.2 到 XBB 后代)的进化过程。我们专注于这一时期的病毒进化,提供了具体的例子,表明 SARS-CoV-2 通过增强刺突(S)蛋白的几个功能,包括其与 ACE2 受体的结合亲和力和逃避体液免疫的能力,从而提高了其适应性。此外,我们探讨了特定突变如何通过结构改变来修饰 S 蛋白的这些功能。本综述提供了关于 SARS-CoV-2 如何在大流行期间提高其适应性并多次引发疫情的进化、分子和结构方面的见解。